Comprehensive Serum Proteomic and Metabolomic Profiles of Pediatric Patients with Moyamoya Disease Reveal Core Pathways
Authors:
Open Access
- 1 September 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 6173-6192
Abstract
Background: Moyamoya disease (MMD) signifies a cerebrovascular disorder with obscure origin and a more rapid and severe progression in children than adults. This investigation aims to uncover age-associated distinctions through proteomic and metabolomic profiling to gain insights into the underlying mechanisms of MMD. Methods: Twelve MMD patients—six children and six adults—along with six healthy controls (HC), participated, each providing a 10 mL blood sample. Serum proteomic and metabolomic analyses were conducted using ultra-performance liquid chromatography and high-resolution mass spectrometry, complemented by bioinformatics to identify differential biomolecules and their interactions. Pathway implications were ascertained using GO and KEGG enrichment analysis. Results: Notable proteomic and metabolomic discrepancies were observed between pediatric and adult MMD subjects. A total of 235 and 216 proteins varied in adult and pediatric cases compared to HCs, with 73 proteins shared. In addition, 129 and 74 anionic, plus 96 and 104 cationic metabolites, were differentially expressed in the pediatric and adult groups, respectively, with 34 anionic and 28 cationic metabolites in common. Age-specific biomolecules further characterized these distinctions. Enrichment analysis pinpointed immunity and inflammation pathways, with vitamin digestion and absorption highlighted as pivotal in pediatric MMD. Conclusion: This study unveils distinct metabolic and proteomic patterns within pediatric and adult MMD patients. The critical role of the vitamin digestion and absorption pathway in the pathogenesis of pediatric MMD offers novel insight into disease mechanisms.Keywords
This publication has 46 references indexed in Scilit:
- Proteomic and metabolomic characterizations of moyamoya disease patient seraBrain and Behavior, 2023
- De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset strokeGenetics in Medicine, 2023
- Data-Independent Acquisition-Based Serum Proteomic Profiling of Adult Moyamoya Disease Patients Reveals the Potential Pathogenesis of Vascular ChangesJournal of Molecular Neuroscience, 2022
- ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancerCancer Medicine, 2022
- Targeted metabolomics analysis of serum amino acid profiles in patients with Moyamoya diseaseAmino Acids, 2021
- Limits and pitfalls of indirect revascularization in moyamoya disease and syndromeNeurosurgical Review, 2020
- Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathyNeuroradiology, 2020
- Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent mannerBiochemical and Biophysical Research Communications, 2020
- Therapeutic advancement of benzothiazole derivatives in the last decennial periodArchiv der Pharmazie, 2018
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969